Wondering if Repligen at around US$113 is starting to look interesting on price, or if the recent weakness is telling you to be cautious about its value? The stock closed at US$113.11, with returns of ...

AI capability is advancing fast. In some domains, it is solving problems that were out of reach just a few years ago. But ...

Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN) and Neurogene (NGNE) with bullish sentiments. Craig-Hallum analyst Matt Hewitt maintained ...

The board at La Liga giants Real Madrid have this week been dealt a blow in their ongoing search for a new head coach.This ...

Iran’s 14-point proposal calls for an end to the war, rather than just an extension of the truce. The proposal, a rebuttal to ...

Borussia Dortmund manager Niko Kovac has hit back at his critics, drawing a bold comparison in the process. He also ...

A royal road for José?A new twist in the saga over Real Madrid’s next manager: Madrid-based newspaper AS told us this ...

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the ...